Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
IsraelRecruitingPHASE2
Conditions
Malignant Melanoma Stage IV
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sheba Medical Center, Ramat Gan, Israel
Contact: Principal Investigator (Jacob Schachter, MD)